Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.

about

Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.

Item

http://www.wikidata.org/entity/Q55310096

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Production and efficacy of a l ...... ysaccharide conjugate vaccine.

@en

Production and efficacy of a l ...... ysaccharide conjugate vaccine.

@nl

type

Item

label

Production and efficacy of a l ...... ysaccharide conjugate vaccine.

@en

Production and efficacy of a l ...... ysaccharide conjugate vaccine.

@nl

prefLabel

Production and efficacy of a l ...... ysaccharide conjugate vaccine.

@en

Production and efficacy of a l ...... ysaccharide conjugate vaccine.

@nl

P1476

Production and efficacy of a l ...... ysaccharide conjugate vaccine.

@en

P2093

Alex Richter

http://www.w3.org/2001/XMLSchema#string

Emily J Kay

http://www.w3.org/2001/XMLSchema#string

Jenny A Herbert

http://www.w3.org/2001/XMLSchema#string

Jon Cuccui

http://www.w3.org/2001/XMLSchema#string

Sherif Abouelhadid

http://www.w3.org/2001/XMLSchema#string

Sian E Faustini

http://www.w3.org/2001/XMLSchema#string

Timothy J Mitchell

http://www.w3.org/2001/XMLSchema#string

P2860

The estimation of the bactericidal power of the blood

Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli.

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli.

Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.

Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes.

Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.

N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli.

P304

3809-3819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2018.05.036

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brendan W Wren

P577

2018-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29778517

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

5999350

http://www.w3.org/2001/XMLSchema#string